Search for: "MUTUAL PHARMACEUTICAL CO., INC."
Results 61 - 80
of 172
Sort by Relevance
|
Sort by Date
4 Dec 2013, 2:38 pm
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
3 Dec 2013, 7:54 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
14 Nov 2013, 7:41 am
Medtronic, Inc., 552 U.S. 312 (2008), Wyeth v. [read post]
31 Oct 2013, 5:00 am
We think that the opinion resembles the First Circuit’s decision in Mutual Pharmaceutical Co. v. [read post]
17 Oct 2013, 5:00 am
Mutual Pharmaceutical Co., 731 F. [read post]
24 Sep 2013, 7:05 pm
Concord EFS, Inc. 13-63Issue: Whether a plaintiff who purchases directly from a member of a price-fixing conspiracy is necessarily a “direct purchaser” under Illinois Brick Co. v. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
12 Sep 2013, 7:37 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
5 Sep 2013, 12:24 pm
It appears from the opinion, id., that the defendant tried to extend Mensing/Mutual Pharmaceutical Co. v. [read post]
30 Jul 2013, 2:01 pm
Lexis 1688, at *17, that is nowhere found in either Mensingor Mutual Pharmaceutical Co. v. [read post]
5 Jul 2013, 5:00 am
Mutual Pharmaceutical Co., 760 F. [read post]
3 Jul 2013, 5:00 am
” Mutual Pharmaceutical Co. v. [read post]
2 Jul 2013, 9:02 am
The lawsuit itself, Mutual Pharmaceutical Co., Inc. v. [read post]
1 Jul 2013, 9:59 pm
Actavis, Inc. and Mutual Pharmaceutical Co. v. [read post]
1 Jul 2013, 10:16 am
(Photo by Sarah Macmillan/Creative Commons) The smoke finally cleared last Monday in Mutual Pharmaceutical Co. v. [read post]
24 Jun 2013, 8:30 pm
A sharply divided Supreme Court ruled (5-4) today in Mutual Pharmaceutical Co., Inc. v. [read post]
24 Jun 2013, 5:25 pm
On remand, the Fifth Circuit must assess whether the University has offered sufficient evidence to prove that its admissions program is narrowly tailored to obtain the educational benefits of diversity.Mutual Pharmaceutical Co. v. [read post]
24 Jun 2013, 12:50 pm
Mutual Pharmaceutical Co., 678 F.3d 30 (1st Cir. 2012), it essentially dared the Supreme Court to take the case and close off what Bartlett viewed as the plaintiff’s last option – a “pure” design defect claim, with no alternative design offered, explicitly amounting to a claim that – under state law − an FDA-approved product should have been pulled from the market.The Supreme Court has obliged. [read post]
21 Jun 2013, 4:46 am
March (3) Mutual Pharmaceutical Co. v. [read post]
16 Jun 2013, 3:49 pm
Mutual Pharmaceutical Co. v. [read post]
